Literature DB >> 26967738

Correction: Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma.

June Y Hou, Alicia Rodriguez-Gabin, Leleesha Samaraweera, Rachel Hazan, Gary L Goldberg, Susan Band Horwitz, Hayley M McDaid.   

Abstract

Entities:  

Year:  2016        PMID: 26967738      PMCID: PMC4788279          DOI: 10.1371/journal.pone.0151750

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
The third author’s name is spelled incorrectly. The correct name is: Leleesha Samaraweera. The correction citation is: Hou JY, Rodriguez-Gabin A, Samaraweera L, Hazan R, Goldberg GL, Horwitz SB, et al. (2013) Exploiting MEK Inhibitor-Mediated Activation of ERα for Therapeutic Intervention in ER-Positive Ovarian Carcinoma. PLoS ONE 8(2): e54103. doi:10.1371/journal.pone.0054103.
  1 in total

1.  Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.

Authors:  June Y Hou; Alicia Rodriguez-Gabin; Leleesha Samaraweera; Leleesha Samaweera; Rachel Hazan; Gary L Goldberg; Susan Band Horwitz; Hayley M McDaid
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.